doi: 10.4140/TCP.n.2021.426.
New Drugs
Affiliations
- PMID: 34452651
- DOI: 10.4140/TCP.n.2021.426
Item in Clipboard
New Drugs
Sr Care Pharm.
.
Abstract
The manuscript contains description of three new medications (vericiguat, tepotinib, tivozanib) which were approved by the US Federal Drug Administration in 2021 and can be used in older populations.
Similar articles
-
Tepotinib: First Approval.Drugs. 2020 Jun;80(8):829-833. doi: 10.1007/s40265-020-01317-9. Drugs. 2020. PMID: 32361823 Review.
-
Tepotinib Hydrochloride.Am J Health Syst Pharm. 2021 Jun 7;78(12):1015-1017. doi: 10.1093/ajhp/zxab116. Am J Health Syst Pharm. 2021. PMID: 33899081 No abstract available.
-
Tepotinib hydrochloride for the treatment of non-small cell lung cancer.Drugs Today (Barc). 2021 Apr;57(4):265-275. doi: 10.1358/dot.2021.57.4.3238323. Drugs Today (Barc). 2021. PMID: 33851690 Review.
-
Tepotinib Inhibits the Epithelial-Mesenchymal Transition and Tumor Growth of Gastric Cancers by Increasing GSK3β, E-Cadherin, and Mucin 5AC and 6 Levels.Int J Mol Sci. 2020 Aug 21;21(17):6027. doi: 10.3390/ijms21176027. Int J Mol Sci. 2020. PMID: 32825724 Free PMC article.
-
Approved spectrofluorimetric strategies for assurance of three modern antineoplastic drugs: tepotinib, sotorasib, and darolutamide in their dose forms and biological liquids utilizing mercurochrome.Luminescence. 2022 Apr;37(4):656-664. doi: 10.1002/bio.4206. Epub 2022 Feb 17. Luminescence. 2022. PMID: 35142060
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
